Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061962
Filing Date
2013-11-14
Accepted
2013-11-14 16:47:00
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v360013_10q.htm 10-Q 543495
2 EXHIBIT 31.1 v360013_ex31-1.htm EX-31.1 8582
3 EXHIBIT 31.2 v360013_ex31-2.htm EX-31.2 8966
4 EXHIBIT 32 v360013_ex32.htm EX-32 6281
5 GRAPHIC ft0002img-1.jpg GRAPHIC 9033
  Complete submission text file 0001144204-13-061962.txt   3434814

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ovit-20130930.xml EX-101.INS 405866
7 XBRL TAXONOMY EXTENSION SCHEMA ovit-20130930.xsd EX-101.SCH 40435
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20130930_cal.xml EX-101.CAL 27540
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20130930_def.xml EX-101.DEF 176050
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20130930_lab.xml EX-101.LAB 251227
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20130930_pre.xml EX-101.PRE 213563
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28347 | Film No.: 131220877
SIC: 2834 Pharmaceutical Preparations